se of 18F-PSMA-11 PET for detection of lesions in iodine refractory thyroid cancers

niversity Hospital Ghent0 个研究点目标入组 20 人开始时间: 2021年9月29日最近更新: 2023年9月18日

试验速览

暂无简介。

•-Patient is 18 years or older.
•-Signed Informed Consent.
•-Subject is diagnosed with a histologically confirmed differentiated thyroid carcinoma, that is considered RAI refractory.
•-Subject should have a routine clinical 18F-FDG PET/CT performed within two months prior to the study scan.
•-Female patients should be either post-menopausal, surgically sterile, or using effective contraceptive methods (failure rate less than 1% per year when used consistently and correctly: combined hormonal contraception associated with inhibition of ovulation, progestogen-only hormonal contraception associated with inhibition of ovulation, intrauterine device, intrauterine hormone-releasing system, bilateral tubal occlusion, vasectomized partner, sexual abstinence).
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•-Patient has known other active malignancy.
•-Patient is potentially pregnant (urinary hCG test can be performed in case of doubt) or breastfeeding.
•-Patient is mentally or legally incapacitated.

发起方

niversity Hospital Ghent